Literature DB >> 4719211

The effect of glucagon on serum gastrin. I. Studies in normal subjects.

J Hansky, C Soveny, M G Korman.   

Abstract

Serum gastrin has been determined by radioimmunoassay in 13 subjects free of gastrointestinal disease, in the basal state, and following the intravenous injection of 1 mg glucagon. Serum gastrin fell from a mean +/- SEM level of 50.3 +/- 6.7 to 9.4 +/- 3.3 pg/ml at 30 minutes after injection, significant at p<0.005. This is similar to the response previously reported for secretin and indicates a role for glucagon in the control of gastrin release.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4719211      PMCID: PMC1412743          DOI: 10.1136/gut.14.6.457

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  7 in total

1.  INHIBITION OF GASTRIC ACID SECRETION BY SECRETIN AND BY ENDOGENOUS ACID IN THE DUODENUM.

Authors:  K G WORMSLEY; M I GROSSMAN
Journal:  Gastroenterology       Date:  1964-07       Impact factor: 22.682

2.  Radioimmunoassay of gastrin in human serum.

Authors:  J Hansky; M D Cain
Journal:  Lancet       Date:  1969-12-27       Impact factor: 79.321

3.  Effect of secretin on serum gastrin as measured by immunoassay.

Authors:  J Hansky; C Soveny; M G Korman
Journal:  Gastroenterology       Date:  1971-07       Impact factor: 22.682

4.  Inhibition of pentagastrin-induced gastric acid secretion in man by glucagon given intravenously.

Authors:  G Dotevall; N G Kock; A Walan
Journal:  Scand J Gastroenterol       Date:  1969       Impact factor: 2.423

5.  The effect of secretin on the basal gastric acid secretion in man.

Authors:  H Petersen
Journal:  Scand J Gastroenterol       Date:  1969       Impact factor: 2.423

6.  Secretin: the enterogastrone released by acid in the duodenum.

Authors:  L R Johnson; M I Grossman
Journal:  Am J Physiol       Date:  1968-10

7.  Influence of glucagon on pancreatic exocrine secretion in man.

Authors:  W P Dyck; E C Texter; J M Lasater; N C Hightower
Journal:  Gastroenterology       Date:  1970-04       Impact factor: 22.682

  7 in total
  11 in total

1.  Hormonal control of gastrointestinal motility.

Authors:  R F Harvey
Journal:  Am J Dig Dis       Date:  1975-06

2.  Criteria for the glucagon provocative test in the diagnosis of gastrinoma.

Authors:  Chikashi Shibata; Masayuki Kakyo; Makoto Kinouchi; Naoki Tanaka; Koh Miura; Takeshi Naitoh; Hitoshi Ogawa; Fuyuhiko Motoi; Shinichi Egawa; Tatsuya Ueno; Hiroo Naito; Michiaki Unno
Journal:  Surg Today       Date:  2012-09-16       Impact factor: 2.549

3.  Effect of glucagon on gastric and pancreatic secretion and peptic ulcer formation in cats.

Authors:  S J Konturek; T Demitrescu; T Radecki; P Thor; A Pucher
Journal:  Am J Dig Dis       Date:  1974-06

4.  Effect of glucagon on serum gastrin. II. Studies in pernicious anaemia and the Zollinger-Ellison syndrome.

Authors:  M G Korman; C Soveny; J Hansky
Journal:  Gut       Date:  1973-06       Impact factor: 23.059

5.  Effect of glucagon on vagally induced gastric acid secretion in humans.

Authors:  F B Loud; J J Holst; J Christiansen; J F Rehfeld
Journal:  Dig Dis Sci       Date:  1988-04       Impact factor: 3.199

6.  Effects of endogenous hyperglucagonemia on lower esophageal sphincter pressure and gastric acid secretion.

Authors:  R D Tolin; G Boden; R S Fisher
Journal:  Dig Dis Sci       Date:  1979-04       Impact factor: 3.199

7.  The effect of histamine H2-receptor blockade with metiamide on serum gastrin levels in man.

Authors:  G O Barbezat; B Grant; S Bank; A Vinik
Journal:  Gut       Date:  1975-03       Impact factor: 23.059

8.  The glucagon provocative test for the diagnosis and treatment of Zollinger-Ellison syndrome.

Authors:  Chikashi Shibata; Yuji Funayama; Kouhei Fukushima; Tatsuya Ueno; Atsushi Kohyama; Kennichi Satoh; Tooru Shimosegawa; Tetsuya Yamagiwa; Iwao Sasaki
Journal:  J Gastrointest Surg       Date:  2007-10-11       Impact factor: 3.452

9.  The interaction of glucagon and pentagastrin on the lower oesophageal sphincter in man and dog.

Authors:  H M Jennewein; F Waldeck; R Siewert; F Weiser; R Thimm
Journal:  Gut       Date:  1973-11       Impact factor: 23.059

10.  Lowering of fasting and food stimulated serum immunoreactive gastric inhibitory polypeptide (GIP) by glucagon.

Authors:  R Ebert; R Arnold; W Creutzfeldt
Journal:  Gut       Date:  1977-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.